Skip to content

Menu

About UsOur PracticeContactTopics

Search

Close

Enter Search Terms

Health Law Diagnosis

Monitoring the Pulse of Health Care and Life Sciences

in-person exam

Subscribe to in-person exam via RSS

DEA Allows Providers to Prescribe Controlled Substances Without an In-Person Medical Examination During COVID-19 Public Health Emergency

By Nathaniel Arden on March 18, 2020

Posted in COVID-19, Pharmaceuticals and Biologics, Pharmacy Law, Physicians and Allied Health Professionals, Telemedicine

The Federal Drug Enforcement Agency (DEA) issued guidance permitting DEA-registered practitioners to prescribe controlled substances without an in-person medical exam of the patient for the duration of the COVID-19 public health emergency.
Continue Reading DEA Allows Providers to Prescribe Controlled Substances Without an In-Person Medical Examination During COVID-19 Public Health Emergency

Health Law Diagnosis

Connecticut•Massachusetts•New York•Washington DC•Rhode Island•Florida•California•Delaware•Pennsylvania•Texas

Join Us on Facebook View Our LinkedIn Profile RSS Follow Us on X

Privacy PolicyTerms of UseDisclaimerCalifornia Privacy Rights Notice

Home
About Us
Our Practice
Contact

The Robinson+Cole Health Law Group serves health care and life sciences clients regionally, nationally and globally. We are experienced lawyers trained to help clients meet their business objectives within complicated legal and regulatory environments. Our team understands the challenges of competition, regulation, and resource allocation. We focus on providing practical solutions and responsive counsel to our clients.

Topics

Topics

Archives

Archives

Copyright © 2025, Robinson & Cole LLP. All Rights Reserved.

Law blog design & platform by LexBlog

Please note that as of January 1, 2023 our Privacy Policy has changed. Click here for details on our new terms.